BYD Company Limited
002594
Orient Group Incorporation
600811
Hanshow Technology
301275
4
Contemporary Amperex Technology
300750
5
Kweichow Moutai
600519
CN Stock MarketDetailed Quotes
002198 Guangdong Jiaying Pharmaceutical
- 7.23
- +0.09+1.26%
Market Closed Mar 4 15:00 CST
3.67BMarket Cap301.25P/E (TTM)
7.23High7.04Low73.11KlotVolume7.10Open7.14Pre Close52.29MTurnover1.44%Turnover Ratio106.32P/E (Static)507.51MShares9.3052wk High4.96P/B3.67BFloat Cap5.8352wk Low7.85Limit Up507.48MShs Float20.79Historical High6.43Limit Down2.66%Amplitude1.02Historical Low0.05Dividend TTM7.15Avg Price31.75KlotAsk0.69%Div YieldTTM100Lot Size38.87KlotBid
Guangdong Jiaying Pharmaceutical News
Jiaying Pharmaceutical: 2025-006 Announcement on the progress of share repurchases
Jiaying Pharmaceutical: Announcement of Resolutions of the Fifth Interim Meeting of the 7th Board of Directors
Jiaying Pharmaceutical: Public Opinion Management System
Jiaying Pharmaceutical: Announcement on the progress of share repurchases
Jiaying Pharmaceutical: Announcement on the repurchase ratio of the company\'s shares reaching 1% and the progress of the repurchase
Jiaying Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Jiaying Pharmaceutical: Announcement on the progress of share repurchases
Jiaying Pharmaceutical: Legal Opinion of the 2024 Third Extraordinary General Meeting of Shareholders of Jiaying Pharmaceutical
Jiaying Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Jiaying Pharmaceutical: 2024 Employee Stock Ownership Plan
Jiaying Pharmaceutical: Repurchase Report
Jiaying Pharmaceutical: Announcement on the change of name of its wholly-owned subsidiary and completion of commercial and commercial registration
Jiaying Pharmaceutical: Guangdong Jiaying Pharmaceutical Co., Ltd. 2024 Third Extraordinary General Meeting of Shareholders Meeting Data
Jiaying Pharmaceutical: Announcement on the repurchase of company shares by independent directors
Jiaying Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Jiaying Pharmaceutical: 002198 Jiaying Pharmaceutical Investor Relations Management Information 20241218
Jiaying Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft)
Jiaying Pharmaceutical: All directors\' commitment that this share repurchase will not impair the listed company\'s ability to fulfill its debts and continue to operate
Jiaying Pharmaceutical: Announcement of Resolutions of the Fourth Interim Meeting of the 7th Board of Directors
Jiaying Pharmaceutical: Announcement on receiving a proposal from the chairman to repurchase the company\'s shares